Barbara Ryan - 15 Jan 2022 Form 4 Insider Report for INVO Bioscience, Inc. (INVO)

Role
Director
Signature
/s/ Barbara Ryan
Issuer symbol
INVO
Transactions as of
15 Jan 2022
Transactions value $
$0
Form type
4
Filing time
18 Jan 2022, 20:26:35 UTC
Previous filing
20 Oct 2021
Next filing
11 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INVO Common Stock Award $0 +8,588 +69% $0 21,053 15 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INVO Stock Option Award $0 +10,435 $0 10,435 15 Jan 2022 Common Stock 10,435 $3.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in monthly increments over a period of twelve months from the date of grant.